Status:
RECRUITING
ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery
Lead Sponsor:
Institute of Automation, Chinese Academy of Sciences
Conditions:
Hepatocellular Carcinoma
Eligibility:
All Genders
18-80 years
Phase:
PHASE1
Brief Summary
In this study, the investigators will detect hepatocellular carcinoma lesions using fluoescence imaging with ITGA6 targeting probes during tumor resection surgery. The aim is to evaluate wether intrao...
Eligibility Criteria
Inclusion
- Patients who have been diagnosed with hepatocellular carcinoma.
- Planned to receive hepatectomy.
- Liver function Child-Pugh A.
- ITGA6 was validated highly expressed preoperatively.
- Aged 18 to 80, and the expected lifetime is longer than 6 months.
- Approved to sign the informed consent.
Exclusion
- Allergic to Cy7.
- Enrolled in other trials in the past 3 months.
- Another malignant tumor was found.
- Undesirable function of heart, lung, kidney, or any other organs.
- Unable to tolerate a hepatectomy.
- The researchers considered inappropriate to be included.
Key Trial Info
Start Date :
January 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2039
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06204835
Start Date
January 7 2024
End Date
December 31 2039
Last Update
May 22 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong
Guangzhou, Guangdong, China
2
Sichuan
Luzhou, Sichuan, China